The University of Edinburgh

MiChro is an innovative app that empowers users to achieve optimal health. By leveraging cutting-edge principles of chronobiology, MiChro provides personalized recommendations tailored to each user’s health conditions, lifestyle, and goals. Our app integrates advanced data analytics and machine learning to continuously evolve, delivering actionable insights into nutritional status and dietary habits. This ensures users can make sustainable, long-term improvements to their health while enjoying a seamless, engaging experience. Current nutrition apps often fail to deliver the personalization users need. They rely on tedious manual entry, overlook individual restrictions and preferences, and lack interactivity—leading to poor user retention and limited impact. MiChro revolutionizes the nutrition app experience with its intuitive design, personalized features, and dynamic engagement, ensuring every user feels supported on their health journey. Join us in redefining health empowerment through personalized nutrition and advanced technology. Key words: Personalized Nutrition, Chronobiology, HealthTech, AI-powered Health, Nutritional Optimization, Machine Learning for Health, Health Empowerment, Lifestyle Medicine

Lentitek is a cell and gene therapy company focused on developing innovative treatments for cancer patients. The company is dedicated to making advanced therapeutics more accessible by enhancing the production of lentiviral vectors, which are essential for gene therapies. Lentitek employs a proprietary method that utilizes a novel promoter and a triple transfection production process to significantly increase viral yields by tenfold or more. This approach not only improves the efficiency of lentiviral production but also aims to lower production costs for healthcare providers, thereby broadening the availability of its therapies to a larger patient population.

The National Biofilms Innovation Centre (NBIC) serves as a collaborative hub uniting academia, industry, government, and public policy to address the challenges posed by biofilms, which significantly impact global economic activity across sectors such as food, health, shipping, clean water, and energy. Supported by funding from the BBSRC, Innovate UK, and Hartree Centre, NBIC's mission focuses on fostering a network for research and innovation that catalyzes partnerships with industry to drive breakthrough innovations. The Centre facilitates the exploration of unmet needs and the exchange of ideas through various initiatives, including roadmaps, workshops, and conferences. Additionally, NBIC is dedicated to nurturing the next generation of scientists through PhD and Post-Doc programs, alongside entrepreneurial training, aimed at enhancing their expertise and understanding of the commercial landscape while promoting the creation of new start-ups.

BioCaptiva is a company focused on advancing liquid biopsy technology for the early diagnosis and monitoring of challenging-to-detect cancers. The company's innovative platform captures circulating free DNA from patients' blood in greater quantities than existing methods, addressing the limitations of current liquid biopsy tests. By enhancing the ability to detect and monitor cancer, BioCaptiva aims to provide healthcare professionals with improved tools for disease management, ultimately transforming the landscape of cancer diagnostics.

Simon Community Scotland is a charitable social firm offering home and support to the homeless people.

Mocean Energy is a technology developer based in Edinburgh, United Kingdom, specializing in harnessing wave energy to promote a transition to a zero-carbon future. Established in 2015, the company has created an innovative energy converter that efficiently transforms kinetic energy from ocean waves into electricity. This converter supports a power take-off mechanism, allowing for the reliable and cost-effective generation of renewable energy. Mocean Energy's solutions are designed to power various subsea applications, including control systems, remotely operated vehicles, and autonomous underwater vehicles, thereby enhancing the use of sustainable energy in maritime operations.

Sphere Fluidics Limited is a life sciences company focused on developing innovative technologies for single-cell analysis and characterization. The company offers unique products and collaborative research and development services that aid in the discovery of new cell strains and molecules. Its cell analysis systems facilitate the screening and isolation of rare and valuable biological variants, catering to various applications in research, therapeutic development, bioproduction, and diagnostics. By streamlining these processes, Sphere Fluidics enables clients to reduce costs and time, thereby accelerating advancements in biological and biopharmaceutical discovery.